Hubei Hongyuan Pharmaceutical Technology (301246) Stock Overview

Hubei Hongyuan Pharmaceutical Technology Co., Ltd. engages in the production and sale of organic chemical raw materials, pharmaceutical intermediates, bulk drugs, preparations, and new energy materials in China. It provides active pharmaceutical ingredients, such as metronidazole, metronidazole benzoate, dimenidazole, and acyclovir; pharmaceutical ingredients, including glyoxylic acid, 2-methylimidazole, and 2-methyl-5-nitroimidazole; organic chemical raw materials comprising glyoxal and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. The company was founded in 2002 and is headquartered in Huanggang, China.